A Study of Belimumab in Treating Symptomatic Waldenstroms Macroglobulinaemia
Clinical trial NCT01142011 · UNKNOWN
Trial details
- NCT number
- NCT01142011
- Sponsor
- Cancer Trials Australia
- Status
- UNKNOWN
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2009-11-01
- Primary completion
- 2012-06-01
- Enrollment
- 15
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.